Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study

Background: The present study aimed to examine the odds of cholangiocarcinoma (CCA) in patients with proton pump inhibitors (PPIs) use. Methods: A nested case-control study design was employed using data obtained from Taiwan's National Health Insurance Research Database. In total, 2,293 patient...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Pharmacol
Auteurs principaux: Peng, Yen-Chun, Lin, Cheng-Li, Hsu, Wan-Yun, Chow, Wai-Keung, Lee, Show-Wu, Yeh, Hong-Zen, Chen, Chia-Chang, Kao, Chia-Hung
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2018
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6037835/
https://ncbi.nlm.nih.gov/pubmed/30018559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00718
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires